Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Apr;91(4):444-445.
doi: 10.1136/jnnp-2019-321694. Epub 2019 Nov 6.

Transition from ketogenic diet to triheptanoin in patients with GLUT1 deficiency syndrome

Elodie Hainque  1   2 , Aurélie Meneret  1   2 , Domitille Gras  3 , Mariana Atencio  1 , Marie-Pierre Luton  1 , Magali Barbier  1 , Anne De Saint Martin  4 , Thierry Billette de Villemeur  5 , Chris Ottolenghi  6 , Emmanuel Roze  1   2 , Fanny Mochel  7   8
Affiliations

Transition from ketogenic diet to triheptanoin in patients with GLUT1 deficiency syndrome

Elodie Hainque et al. J Neurol Neurosurg Psychiatry. 2020 Apr.
No abstract available

Keywords: metabolic disease; movement disorders.

PubMed Disclaimer

Conflict of interest statement

Competing interests: FM has a patent on the use of triheptanoin in GLUT1-DS (WO2014093901), which has been issued. AM reports non-financial support from ABBVIE, outside the submitted work. ER reports grants, personal fees and non-financial support from Orkyn, grants, personal fees and non-financial support from Aguettant, grants, personal fees and non-financial support from Merz pharma, grants from Ipsen, personal fees from Medday pharma, personal fees from Retrophin, grants and non-financial support from Elivie, grants from Fondation Desmarest, grants from Fonds de dotation Brou de Laurière, grants from Agence Nationale de la Recherche, grants from AMADYS, grants, personal fees and non-financial support from Everpharma, personal fees and non-financial support from Movement Disorders Society, personal fees from European Academy of Neurology, personal fees from International Association of Parkinsonism and related Disorders, non-financial support from Merck, non-financial support from Dystonia Coalition, non-financial support from Dystonia Medical Research Foundation, outside the submitted work.

Publication types

Supplementary concepts